The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
CNBG data shows COVID-19 booster shot leads to robust immunity
The inactivated vaccine developed by the China National Biotec Group (CNBG) affiliated with Sinopharm has been proved safe and effective in three-shot vaccination clinical trials among people aged three and above.
August13,2021
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
